Massimo Lopes

18PUBLICATIONS
86CO-AUTHORS
Neurology and neuromuscular diseasesMolecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cell development, proliferation and death
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 17, 2026
Non-canonical ATR signalling via NBS1 phosphorylation propagates fork slowing from stressed to unperturbed nuclear regions.

|Dec 17, 2025
MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1/2-deficient tumors.

Hülya Dogan, Martin Liptay, Joana S Barbosa

|Dec 17, 2025
The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesis.

Jonas Fullin, Ebru Topçu, Karolina A Zielińska

|Nov 29, 2025
Nucleoplasmic Lamin A/C controls replication fork restart upon stress by modulating local H3K9me3 and ADP-ribosylation levels.

Veronica Cherdyntseva, Joanna Paulson, Daniel González-Acosta

|Oct 28, 2025
H2BK120ub and its reader RNF169 sequentially regulate replication fork remodeling and stability.

Filip D Duzanic, Vaishnavi Mohana-Natarajan, Samuele Fisicaro

|May 24, 2024
H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours.

Diego Dibitetto, Martin Liptay, Francesca Vivalda

Pageof 3

Frequent Collaborators

3 joint publications

Henriette Stoy

3 joint publications

Jonas A Schmid

3 joint publications

Robert Grosse

3 joint publications

Daniel González-Acosta